MINIMED
Weitere Aktien aus dem Sektor Gesundheit
Über MINIMED GROUP, INC.
MiniMed Group, Inc. is a medical technology company, which develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.
Q4 2025 MiniMed Group Inc Earnings Release
03.06.2026
10:45
Veröffentlichungen von Geschäftszahlen
Q4 2025 MiniMed Group Inc Earnings Call
03.06.2026
12:45
Telekonferenzen und Präsentationen zu Gewinnen